PHM431 Pharmacotherapeutics (16)

The focus of this subject is pharmacotherapeutics, which is the study of the therapeutic use of medicines and their effects, both beneficial and deleterious. To successfully complete this course you will need to have a firm foundational knowledge in pharmacology and pathophysiology.
The topics in this subject have also been aligned with the other 4th year Pharmacy subjects so that similar topics are delivered concurrently to help facilitate the integration of your pharmacy knowledge from other subjects. The topics and tasks included in this subject have been designed so that by the time you have finished you should be able to analyse a patient's medication regimen and design a new regimen which enhances their health outcomes. Students entering this subject are assumed to have completed the first 3 years of the Bachelor of Pharmacy.

Availability

Year-long Period 1 (31)
On Campus
Orange Campus

Continuing students should consult the SAL for current offering details: PHM431. Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System

HD/FL

Duration

One session

School

School of Biomedical Sciences

Enrolment Restrictions

Available only to students enrolled in the Bachelor of Pharmacy and Bachelor of Pharmacy (Honours) courses.

Not available to students who have successfully completed PHM430.

Prerequisites

BMS310 and ( BMS340 or BMS347 )

Subject Relationships

PHM430 replaced by PHM431

Incompatible Subjects

PHM430

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to identify the right drug for the right patient to obtain the right response;
  • be able to evaluate the pharmacological impacts of a patient's medication on their health or quality of life;
  • be able to identify the pharmacological impacts of medication on patient adherence;
  • be able to develop strategies to minimise the impact of drug dependence, resistance or tolerance on patient health outcomes; and
  • be able to analyse a patient's drug regimen and develop new drug regimens to improve the patient's health and quality of life.

Syllabus

This subject will cover the following topics:
  • Cardiovascular system: e.g. hypertension
  • Respiratory system: e.g. COPD
  • Immune system: e.g. autoimmune
  • Oncology e.g. leukaemia
  • Reproductive system: e.g. BPH
  • Nervous system: e.g. depression
  • Endocrine systems: e.g. diabetes
  • Skeletal system: e.g. osteoporosis
  • Integumentary system: e.g. psoriasis
  • Sensory system: e.g. glaucoma
  • Digestive system: e.g. IBD
  • Urinary system: e.g. chronic kidney disease
  • Specific population groups: e.g. geriatrics

The information contained in the CSU Handbook was accurate at the date of publication: June 2022. The University reserves the right to vary the information at any time without notice.

Back